Science ❯ Biology ❯ Immunology
Chronic Inflammatory Conditions Complement System Activation Drug Delivery Cytokine Research Cytokines Chronic Diseases
The $14-per-share agreement brings Lilly a clinical portfolio targeting chronic inflammation, with closing targeted in the first half of 2026.
